Operational research to improve HIV prevention in the United States

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 5, 2012, Pages 530-536

  Herbst, Jeffrey H ^a   Glassman, Marlene ^a   Carey, James W ^a   Painter, Thomas M ^a   Gelaude, Deborah J ^a   Fasula, Amy M ^a   Raiford, Jerris L ^a   Freeman, Arin E ^a   Harshbarger, Camilla ^a   Viall, Abigail H ^a   Purcell, David W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Combination prevention; HIV AIDS prevention; Operational research; Treatment as prevention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AWARENESS; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MASS SCREENING; MEDICAL CARE; MEDICAL RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; UNITED STATES;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; OPERATIONS RESEARCH; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84859772315     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182479077     Document Type: Review

References (59)

1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
2. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363:2587-2599.
3. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. For the CAP-RISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
4. Thigpen MC, Kebaabetswe PM, Smith DK, et al. Daily oral antiretro-viral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. Paper presented at: 6th International AIDS Society Conference on HIV Patho-genesis, Treatment, and Prevention (IAS 2011); July 17-20, 2011; Rome, Italy.
5. Baeten J, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heteroseuxal African men and women: the Partners PrEP Study. Paper presented at: 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2011); 2011; July 17-20, Rome, Italy.
6. Shattock RJ, Warren M, McCormack S, et al. Turning the tide against HIV. Science. 2011;333:42-43.
7. HIV treatment as prevention\it works (editorial). Lancet. 2011;377:1719.
8. Hammer SM. Antiretroviral treatment as prevention. N Engl J Med. 2011;365:561-562.
9. Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS. 2010;24(suppl 4): S70-S80.
10. Granich R, Crowley S, Vitoria M, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010;5:298-304.
11. Kurth AE, Celum C, Baeten JM, et al. Combination HIV prevention: significance, challenges and opportunities. Current HIV/AIDS Report. 2011;8:62-72.
12. Centers for Disease Control and Prevention. HIV Surveillance Report, 2009. Vol 21. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/-reports/. Accessed October 28, 2011.
13. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS ONE. 2011;6:e17502.
14. Centers for Disease Control and Prevention. HIV surveillance\United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60: 689-693.
15. Centers for Disease Control and Prevention. WISQARS leading causes of death reports 1999-2007. 2010. Available at: http://webappa.cdc. gov/sasweb/ncipc/leadcaus10.html. Accessed November 4, 2011.
16. Centers for Disease Control and Prevention. HIV Surveillance Report, 2008. Atlanta, GA: Centers for Diseae Control and Prevention; 2010.
17. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC: The White House; 2010.
18. Centers for Disease Control and Prevention. High-Impact HIV Preven-tion: CDC's Approach to Reducing HIV Infections in the United States. Atlanta, GA: Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV/AIDS Prevention; 2011.
19. Padian NS, Holmes CB, McCoy SI, et al. Implementation science for PEPFAR. JAcquir Immune Defic Syndr. 2011;56:199-203.
20. Remme JHF, Adam T, Becerra-Posada F, et al. Defining research to improve health systems. PLoS Med. 2010;7:1-7.
21. Fisher A, Foreit J. Designing HIV/AIDS Intervention Studies: An Oper-ations Research Handbook. Washington, DC: Population Council; 2002.
22. Zachariah R, Harries AD, Ishikawa N, et al. Operational research in low-income countries: what, why and how? Lancet. 2009;9:711-717.
23. Schackman BR. Implementation science for the prevention and treatment of HIV/AIDS. J Acquir Immune Defic Syndr. 2010;55(suppl 1):S27-S31.
24. Mshana GH, Wamoyi J, Busza J, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20:649-657.
25. Reid T, van Engelgen I, Telfer B, et al. Providing HIV care in the aftermath of Kenya's post-election violence: Médecins Sans Fromtieres' lessons learned January-March 2008. Confl Health. 2008;2:15.
26. van Griensven J, De Naeyer L, Uwera J. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatr. 2008;8:39.
27. Painter TM, Diaby KL, Matia DM, et al. Women's reasons for not participating in follow-up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ. 2004;329:543.
28. Collins C, Harshbarger C, Sawyer R, et al. The diffusion of effective behavioral interventions project: development, implementation and lessons learned. AIDS Educ Prev. 2006;18(suppl A):5-20. (Pubitemid 44440943)
29. Gandelman AA, DeSantis LM, Reitmeijer CA. Assessing community needs and agency capacity\an integral part of implementing effective evidence-based interventions. AIDS Educ Prev. 2006;18(suppl A):32-43. (Pubitemid 44440945)
30. Dolcini MM, Gandelman AA, Vogan SA, et al. Translating HIV interventions into practice: community-based organizations' experiences with the diffusion of effective behavioral interventions (DEBIs). Soc Sci Med. 2010;71:1839-1846.
31. National Institute of Mental Health. Program announcement 08-166: dissemination, implementation and operational research for HIV prevention. 2008. Available at: http://grants.nih.gov/grants/guide/pa-files/PA-08-166. html. Accessed October 15, 2011.
32. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800.
33. Cohen SM, Van Handel MM, Branson BM, et al. Vital signs: HIV prevention through care and treatment\United States. MMWR Morb Mortal Wkly Rep. 2011;60:1-6.
34. Centers for Disease Control and Prevention. Compendium of evidence-based HIV prevention interventions. 2011. Available at: http://www.cdc. gov/hiv/topics/research/prs/evidence-based-interventions.htm. Accessed November 6, 2011.
35. Charania MR, Crepaz N, Guenther-Gray C, et al. Efficacy of structural-level condom distribution interventions: A meta-analysis of U.S. and international studies, 1998-2007. AIDS Behav. 2011;15:1283-1297.
36. Palmateer N, Kimber J, Hickman M, et al. Evidence for the effectiveness of sertile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105:844-859.
37. Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS. 2010;24: 729-734.
38. Farnham PG, Hutchinson AB, Sansom SL, et al. Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Rep. 2008;123(suppl 3):51-62.
39. Shrestha RK, Clark HA, Sansom SL, et al. Cost-effectiveness of finding new HIV diagnoses using rapid HIV testing in community-based organizations. Public Health Rep. 2008;123(suppl 3):94-123.
40. Lasry A, Sansom SL, Hicks KA, et al. A model for allocating CDC's HIV prevention resources in the United States. Health Care Mang Sci. 2011;14:115-124.
41. Campsmith ML, Rhodes PH, Hall HI, et al. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-624.
42. Schwarcz S, Hsu L, Dilley J, et al. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J Acquir Immune Defic Syndr. 2006;43:491-494. (Pubitemid 44737109)
43. Centers for Disease Control and Prevention. Late HIV testing\34 states, 1996-2005. MMWR Morb Mortal Wkly Rep. 2009;58:661-665.
44. Nelson KM, Thiede H, Hawes SE, et al. Why the wait? Delayed HIV diagnosis among men who have sex with men. J Urban Health. 2010;87: 642-655.
45. Heffelfinger JD, Sullivan PS, Branson BM, et al. Advancing HIV prevention demonstration projects: new strategies for a changing epidemic. Public Health Rep. 2008;123(suppl 3):5-15.
46. Kimbrough LW, Fisher HE, Jones KT, et al. Accessing social networks with high rates of undiagnosed HIV infection: the Social Networks Demonstration Project. Am J Public Health. 2009;99:1093-1099.
47. Halkitis PN, Kupprat SA, McCree DH, et al. Evaluation of the relative effectiveness of three HIV testing strategies Targeting African-American Men Who Have Sex with Men (MSM) in New York City. Ann Behav Med. 2011;42:361-369.
48. Marks G, Gardner LI, Craw J, et al. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24: 2665-2678.
49. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
50. Mugavero M, Amico KR, Westfall AO, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2011 E-published September 20, 2011.
51. Liau A, Petters S, Crepaz N, For the HIV/AIDS Prevention Research Synthesis (PRS) Team. A systematic review of strategies to link and retain persons living with HIV (PLWH) into HIV primary medical care in the United States. Paper presented at: 2009 National HIV Prevention Conference; August 2009; Atlanta, GA.
52. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423-431. (Pubitemid 40446189)
53. Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52(suppl 2):S214-S222.
54. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180. (Pubitemid 24331334)
55. Palella FJ Jr, Chmiel JS, Moorman AC, et al. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS. 2002;16:1617-1626. (Pubitemid 34921107)
56. Centers for Disease Control and Prevention. Compendium of evidence-based HIV behavioral interventions: medication adherence chapter 2011. Available at: http://www.cdc.gov/hiv/topics/research/prs/ma-chapter. htm. Accessed November 20, 2011.
57. Eaton LA, Kalichman SC. Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165-172.
58. Mansergh G, Koblin BA, Colfax GN, et al. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55:E14-E15.
59. Centers for Disease Control and Prevention. Program Announcement 10-10181: Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS. Atlanta, GA: Centers for Disease Control and Prevention; 2010.